Scotland-based biotech Invizius has completed a Phase I clinical study, assessing its dialysis priming product H-Guard. H-Guard is a specialised medical device coating indicated for use in dialysis ...
First patients treated with H-Guard® at the National Institute for Health and Care Research Manchester Clinical Research Facility MHRA approves continuation of Invizius’s first-in-human clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results